✦ LIBER ✦

Association of in vitro chemotherapy drug resistance assays in ovarian cancer patients with BRCA1/2 mutations

✍ Scribed by Lee, J.; Menzin, A.W.; John, V.S.; Lovecchio, J.L.; Whyte, J.S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of BRCA1 and BRCA2 Mutations

✍ Yang, Da; Khan, Sofia; Sun, Yan; Hess, Kenneth; Shmulevich, Ilya; Sood, Anil K.; 📂 Article 📅 2011 🏛 American Medical Association 🌐 English ⚖ 486 KB

Secondary BRCA1/2 mutations are associat

✍ B. Norquist; T. Taniguchi; K. Wurz; B. Karlan; E. Villegas; W. Sakai; E. Swisher 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Long-Term Ovarian Cancer Survival Associ

✍ McLaughlin, J. R.; Rosen, B.; Moody, J.; Pal, T.; Fan, I.; Shaw, P. A.; Risch, H 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 462 KB

Ovarian cancer survival in Ashkenazi Jew

✍ S.J. Ramus; A. Fishman; P.D.P. Pharoah; S. Yarkoni; M. Altaras; B.A.J. Ponder 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 64 KB

8006 Improved outcome after first line c

✍ Seynaeve, C.; Hoogwerf, D.; Kriege, M.; Beugelink, S.; Jager, A.; Collee, J.; Be 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A breast/ovarian cancer patient with ger

✍ Ramus, Suman J.; Friedman, Lori S.; Gayther, Simon A.; Ponder, Bruce A.J.; Bobro 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 283 KB